ZMYND11 and prostate carcinoma: We first established mouse Zmynd11 knockdown in RM1 cell lines, which originated from the prostate cancer of C57BL/6J mice (Fig. 2p), and implanted these cells orthotopically into the prostate of C57BL/6J male mice.